Zobrazeno 1 - 7
of 7
pro vyhledávání: '"S A, Kuross"'
Autor:
John C. Michalak, James N. Ingle, S. A. Kuross, Jacqueline M. Lafky, Andre T. Baron, Vera J. Suman, John W. Kugler, Araba A. Adjei, L. Geeraerts, Nita J. Maihle, Edith A. Perez, Alan K. Hatfield
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 13(8)
Docetaxel has yielded promising response rates as a component of doxorubicin-based combination schedules in patients with metastatic breast cancer, including docetaxel/doxorubicin and docetaxel/doxorubicin/cyclophosphamide (AC). This randomized two-s
Autor:
J C, Buckner, P J, Schomberg, W L, McGinnis, T L, Cascino, B W, Scheithauer, J R, O'Fallon, R F, Morton, S A, Kuross, J A, Mailliard, A K, Hatfield, J T, Cole, P D, Steen, A M, Bernath
Publikováno v:
Cancer. 92(2)
The current study was conducted to determine whether the addition of interferon-alpha (IFN-alpha) to treatment with radiation therapy and carmustine (BCNU) improves time to disease progression or overall survival in patients with high-grade glioma.Pa
Autor:
J R, Berenson, L S, Rosen, A, Howell, L, Porter, R E, Coleman, W, Morley, R, Dreicer, S A, Kuross, A, Lipton, J J, Seaman
Publikováno v:
Cancer. 91(7)
This study evaluated the dose-response relation for zoledronic acid, a new generation high potency bisphosphonate, given as a 5-minute infusion in patients with malignant osteolytic disease.Two-hundred eighty patients with osteolytic lesions due to m
Autor:
P A, Burch, M, Block, G, Schroeder, J W, Kugler, D J, Sargent, T A, Braich, J A, Mailliard, J C, Michalak, A K, Hatfield, K, Wright, S A, Kuross
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(9)
There continues to be a need for new systemic approaches for the treatment of advanced pancreatic cancer. The purpose of this study was to compare the antitumor activity of the somatostatin analogue octreotide to 5-fluorouracil chemotherapy in a Phas
Autor:
J N, Ingle, S A, Kuross, J A, Mailliard, C L, Loprinzi, S H, Jung, R A, Nelimark, J E, Krook, H J, Long
Publikováno v:
Cancer. 74(6)
Doxorubicin generally is considered to be the most effective single chemotherapeutic agent for the treatment of breast cancer. The major cumulative dose-limiting toxicity is cardiac toxicity, which may be related to the formation of free radicals wit
Publikováno v:
Blood. 71:876-882
It has been suggested that the development of sickle RBC membrane defects might be related to abnormal amounts of membrane-associated heme (a term we use in its generic sense to include hemoglobins, hemichromes, and free heme). Techniques previously
Publikováno v:
Progress in clinical and biological research. 319